Edgar Schmitt
3Patents
1h-index
7Co-inventors
37Inventor score
Filing activity: Jan 30, 2008 → Mar 18, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8557533B2 | Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 | Physics | 1 | Active |
| US12084511B2 | Peptide-based compounds for use in the prevention, treatment and/or detection of cancer | Chemistry; Metallurgy | 0 | Active |
| US10729742B2 | Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.